Akttyva Therapeutics develops targeted therapeutics that address cell barrier dysfunction across multiple indications.
Akttyva Therapeutics develops targeted therapeutics that address cell barrier dysfunction across multiple indications.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 30, 2021 | Grant | $255.48K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |